A new Hydrogel-Based Platform to preserve live patient-derived tumour tissues in the lab could pave the way for faster, more ...

Globally, stomach cancer is on the rise in young people, but new research shows that three-quarters of future cases could be ...

Researchers say about three-quarters of gastric cancer cases worldwide are caused by the common bacteria Helicobacter pylori ...

The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

As many as 15.6 million people born between 2008 and 2017 globally are expected to develop gastric cancer sometime in their ...

Hemorrhoids and colon cancer can both cause symptoms of rectal bleeding, but diagnosis and treatment are different. It's ...

2529 Background: Peritoneal carcinomatosis (PC) from GI-tract cancer is associated with prognosis of 3–6 months. Since chemotherapy and surgical procedures showed only limited efficacy, there is no ...

A recent study reveals a concerning rise in appendix cancer among younger adults. Researchers observed a significant increase ...

ImmunoGen, Inc. has announced that its platinum-resistant ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) has been granted FDA accelerated approval.

Introduction: Intraoperative indocyanine green (ICG) is increasingly used in surgery. In metabolic and bariatric surgery, it allows visualization of the tissues and blood supply to anastomoses in real ...

While his partner gave birth to their first child, Helensburgh man Matt Stephenson was receiving chemotherapy.